Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the Article8th Circuit ruling
5 storiesS-1 public filing
1 storyTrade truce expiry Nov 10
1 storySenate committee report Nov 20
1 storyCourt resolves the dismissal and stay motions Nov 20
1 storyComment deadline on the RFI Nov 23
The SEC filed 348 enforcement actions in fiscal 2026, down from 456 a year earlier, obtained $1.095 billion in monetary relief, and returned $731 million to harmed investors.
SoftBank posted a ¥1.12 trillion quarterly loss after a $3.7 billion writedown on U.S. data-center projects, a sign that the costs of the AI buildout are catching up with its biggest backer.
The Senate voted 73-25 to advance a bipartisan permitting bill that speeds power, transmission and mining projects while requiring large data centers to pay more of the grid upgrades they trigger.
FinCEN ordered U.S. financial institutions to stop processing fund transfers involving MEXC Global, a top-20 crypto exchange it says moved $16.7 billion tied to sanctions evasion and cybercrime.
Brelovitug met its primary endpoint in AZURE-4, with 59% and 44% of patients reaching combined virologic and liver-enzyme response at 24 weeks, setting up a 2027 FDA filing.
CMS released $10 billion in second-year rural health awards nine days after its deadline, leaving the scoring formula and a new administrative requirement unexplained.
Anthropic launched Fable 5.2 and Mythos 5.2 a week before its expected IPO, pairing faster, cheaper models with an S-1 that shows a $567 million quarterly operating loss.
A Ninth Circuit panel paused SB 261 and SB 253's Scope 3 reporting on First Amendment grounds while allowing Scope 1 and 2 disclosures to proceed.
The FDA approved Bayer's asundexian for secondary stroke prevention after a 12,327-patient trial cut recurrent ischemic stroke by 26% without a significant rise in major bleeding.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Forrester's Q3 2026 Wave scores ten providers against twenty nine criteria, cutting the field's criteria count for the first time, while a vendor that owns its content finishes last equal.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleWith James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article